Paper Title
Review on Mycobacterium species multidrug resistance
Article Identifiers
Authors
Dr. K. Purna Nagasree , N. Uma amruta , S. Aishwarya amruta , R. Meghana , Jagadeesh Panda
Keywords
Multi drug resistance M.tuberculosis M.leprae Mechanism of drug resistance
Abstract
One major barrier to efficient treatment and disease control is multi-drug resistance (MDR) in Mycobacterium leprae (ML) and Mycobacterium tuberculosis (MTB). An overview of the MDR mechanisms in these infections and the medications used to combat their resistance is give in this abstract. mutations in the genes that code for the targets of drugs or the activation enzymes of drugs or metabolism are frequently the cause of MDR in MTB. Important first-line medications like rifampicin and isoniazid target essential cellular functions including RNA transcription and cell wall formation. Resistance mechanisms, such as changes in genes like rpoB and katG, impair the effectiveness of drugs. Gene alterations such as gyrA and rrs impair second-line medications, such as fluoroquinolones and injectable treatments, increasing treatment obstacles and resulting in extensively drug-resistant tuberculosis (XDR-TB). Similar to this, drug target genes, such as folP1 for dapsone and rpoB for rifampicin, as well as efflux pumps and metabolic pathways, are mutated in M. Leprae resistance mechanisms. Many different types of medications with different mechanisms of action are used to fight MDR in MTB and M.Leprae. Novel treatments targeting alternate routes are being developed in addition to traditional antibiotics. To reduce resistance and improve treatment effectiveness, combination medicines that are customized to each patient's unique resistance profile are crucial. Molecular assays and whole-genome sequencing are two examples of diagnostic breakthroughs that enable prompt therapeutic interventions by facilitating the quick identification of drug resistance mutations.
Downloads
How To Cite (APA)
Dr. K. Purna Nagasree, N. Uma amruta, S. Aishwarya amruta, R. Meghana, & Jagadeesh Panda (August-2024). Review on Mycobacterium species multidrug resistance. INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT, 9(8), a540-a547. https://ijnrd.org/papers/IJNRD2408049.pdf
Issue
Volume 9 Issue 8, August-2024
Pages : a540-a547
Other Publication Details
Paper Reg. ID: IJNRD_226099
Published Paper Id: IJNRD2408049
Downloads: 000121986
Research Area: Pharmacy
Country: visakhapatnam, Andhra pradesh, India
Published Paper PDF: https://ijnrd.org/papers/IJNRD2408049.pdf
Published Paper URL: https://ijnrd.org/viewpaperforall?paper=IJNRD2408049
About Publisher
Journal Name: INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT(IJNRD)
ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar | ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Publisher: IJNRD (IJ Publication) Janvi Wave | IJNRD.ORG | IJNRD.COM | IJPUB.ORG
Licence
This work is licensed under a Creative Commons Attribution 4.0 International License and The Open Definition
Publication Timeline
Article Preview: View Full Paper
Call For Paper
IJNRD is a Scholarly Open Access, Peer-reviewed, and Refereed Journal with a High Impact Factor of 8.76 (calculated by Google Scholar & Semantic Scholar | AI-Powered Research Tool). It is a Multidisciplinary, Monthly, Low-Cost Journal that follows UGC CARE 2025 Peer-Reviewed Journal Policy norms, Scopus journal standards, and Transparent Peer Review practices to ensure quality and credibility. IJNRD provides indexing in all major databases & metadata repositories, a citation generator, and Digital Object Identifier (DOI) for every published article with full open-access visibility.
The INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (IJNRD) aims to advance applied, theoretical, and experimental research across diverse fields. Its goal is to promote global scientific information exchange among researchers, developers, engineers, academicians, and practitioners. IJNRD serves as a platform where educators and professionals can share research evidence, models of best practice, and innovative ideas, contributing to academic growth and industry relevance.
Indexing Coverage includes Google Scholar, SSRN, ResearcherID-Publons, Semantic Scholar (AI-Powered Research Tool), Microsoft Academic, Academia.edu, arXiv.org, ResearchGate, CiteSeerX, ResearcherID (Thomson Reuters), Mendeley, DocStoc, ISSUU, Scribd, and many more recognized academic repositories.
How to submit the paper?
By Our website
Click Here to Submit Paper Online
Important Dates for Current issue
Paper Submission Open For: October 2025
Current Issue: Volume 10 | Issue 10 | October 2025
Impact Factor: 8.76
Last Date for Paper Submission: Till 31-Oct-2025
Notification of Review Result: Within 1-2 Days after Submitting paper.
Publication of Paper: Within 01-02 Days after Submititng documents.
Frequency: Monthly (12 issue Annually).
Journal Type: IJNRD is an International Peer-reviewed, Refereed, and Open Access Journal with Transparent Peer Review as per the new UGC CARE 2025 guidelines, offering low-cost multidisciplinary publication with Crossref DOI and global indexing.
Subject Category: Research Area
Call for Paper: More Details
